Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

Bibliographic Details
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI
_version_ 1797350564728668160
collection DOAJ
first_indexed 2024-03-08T12:46:47Z
format Article
id doaj.art-d1981c02166243f2a5e4e46aa533f30c
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-03-08T12:46:47Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d1981c02166243f2a5e4e46aa533f30c2024-01-21T05:30:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01191Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trialhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI
spellingShingle Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
PLoS ONE
title Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
title_full Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
title_fullStr Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
title_full_unstemmed Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
title_short Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial
title_sort retraction 2 day versus c reactive protein guided antibiotherapy with levofloxacin in acute copd exacerbation a randomized controlled trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI